Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Files Director List to HKEX

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. has filed an updated list of directors and their respective roles with the Hong Kong Stock Exchange. The company’s eighth board of directors comprises Zhao Da Jun (Chairman and Executive Director), Xue Yan (Executive Director), Shen Bo and Yu Xiao Yang (Non-executive Directors), Wang Hong Guang, Lam Siu Wing, and Xu Pei Long (Independent Non-executive Directors), and Qu Ya Nan (Employee Director). Committee memberships are as follows: Zhao Da Jun serves as Chairman of the Strategy Committee; Xue Yan is a member of the Nomination Committee; Shen Bo is a member of the Audit Committee; Wang Hong Guang is Chairman of the Remuneration Committee and a member of both the Strategy and Audit Committees; Lam Siu Wing is Chairman of the Audit Committee and a member of both the Remuneration and Nomination Committees; Xu Pei Long is Chairman of the Nomination Committee and a member of the Strategy and Remuneration Committees. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251126-11929461), on November 26, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)